{
  "docId": "019de074-80bf-72b8-b7b1-d0f771f9e60f",
  "docSlug": "78e7004510e3b27003e9c94a6172e682",
  "documentTitle": "Chimerix | Investor Presentation Deck | 38 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 38,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-80bf-72b8-b7b1-d0f771f9e60f/18",
  "deckHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f",
  "deckJsonHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f.json",
  "deckAnchorHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.28,
        "x": 0.04,
        "y": 0.28
      },
      "kind": "list",
      "text": "Isolated, durable single agent activity: Responses not confounded by combination treatments; Responses were gradual, durable, and multi-focal; Responses observed via most stringent criteria in blinded assessment",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "86ffee77-9029-4866-814f-cfe4c659b32f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.28,
        "x": 0.68,
        "y": 0.28
      },
      "kind": "list",
      "text": "Enhanced activity not required, but likely: Earlier setting associated with higher response rate (performance status, tumor volume); Addition of higher-dose study arm; Biomarker selection supports patient homogeneity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a49b9e1-afb3-44ae-b4e1-6f12d210d9b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.28,
        "x": 0.36,
        "y": 0.28
      },
      "kind": "list",
      "text": "Consistency across multiple endpoints: Responses highly associated with other forms of clinical benefit; PFS and OS favorable to historical benchmarks; Multiple separate analyses suggest longer survival of patients who received ONC201",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef1e7199-da78-42aa-88d8-4bea9fce5ed1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.72,
        "x": 0.14,
        "y": 0.06
      },
      "kind": "title",
      "text": "Multiple unique aspects to ONC201 data support translation to phase 3 success",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7f40315-2861-4662-ae7a-ead932458cf9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "aef246b6-2ce0-41fc-b5b1-eb8650e044f9",
      "evidence": "list/bullet: Consistency across multiple endpoints: Responses highly associated with other forms of clinical benefit; PFS and OS favorable to historical benchmarks; Multiple separate analyses suggest longer survival of p",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}